Cellebrite DI (CLBT) Gross Margin (2020 - 2025)

Cellebrite DI's Gross Margin history runs 6 years deep, the most recent figure standing at 84.71% for Q4 2025.

• On a quarterly basis, Gross Margin rose 88.0% year-over-year to 84.71% in Q4 2025; TTM through Dec 2025 was 84.2%, a 20.0% decrease from a year earlier, with the FY2025 full-year figure at 84.2%, down 20.0% from the prior year.
• Gross Margin advanced to 84.71% in Q4 2025 per CLBT's latest filing, from 83.88% in the prior quarter.
• Across five years, Gross Margin topped out at 85.55% in Q3 2024 and bottomed at 79.07% in Q2 2022.
• The 5-year median for Gross Margin is 83.67% (2022), against an average of 83.23%.
• Across the five-year window, Gross Margin slumped 392 bps in 2022 and soared 498 bps in 2023, its largest moves.
• Year by year, Gross Margin stood at 81.83% in 2021, then rose by 2 bps to 83.61% in 2022, then climbed by 0 bps to 83.96% in 2023, then retreated by 0 bps to 83.84% in 2024, then advanced by 1 bps to 84.71% in 2025.
• Per Business Quant, the three latest CLBT Gross Margin figures stand at 84.71% (Q4 2025), 83.88% (Q3 2025), and 84.39% (Q2 2025).